Skip to content Skip to sidebar Skip to footer
Mesoblast
Mesoblast (ASX:MSB) Reaches Multi-Year High as Ryoncil Revenue Targets US$30M: Is It Still a Buy?
Commercial momentum builds as Mesoblast targets two major 2026 catalysts: Adult label expansion and Revascor BLA filing. Mesoblast (ASX: MSB) closed at A$2.91 last Friday, up 27% over the past month as investors position ahead of the company's expected US$30 million-plus Q2 revenue report. The share price is now close to its January high of…
TechnologyOne
TechnologyOne (ASX: TNE) Wins $54.7M Legal Battle: Is the 34% Dip Now a Buying Opportunity?
TechnologyOne (ASX: TNE) has finally put one of Australia's longest-running employment disputes behind it. The Federal Court threw out a former manager's A$54.7 million claim late last week, clearing the Brisbane-based software company completely. For investors, this removes a legal cloud that has hung over the stock since 2016.  But with shares trading around A$28.35,…
Develop
Develop Global Wins $200m OceanaGold Contract- What It Means for Investors
Develop Global (ASX: DVP) climbed 4% to A$4.36 on Friday after securing a A$200 million underground development contract with global gold producer OceanaGold. The timing is notable: just one day after OceanaGold received final approval under the New Zealand Government’s Fast-track Approvals Act for its Waihi North Project, Develop locked in one of the largest…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here